MedTrace Logo

Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD

NCT03994640 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-06-21

No results posted yet for this study

Summary

Evaluation of myorelaxant effect of cannabis cream.compared to placebo cream in topical skin application in patients with TMD

Conditions

  • Temporomandibular Disorder
  • Myofascial Pain
  • Cannabis
  • Electromyography

Interventions

COMBINATION_PRODUCT

Cannabis Cream

Topical, bilateral skin application of cannabis cream with self-massage of masseter muscles

COMBINATION_PRODUCT

Placebo Cream

Topical, bilteral skin application of placebo cream with self-massage of masseter muscles

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-10-01
Completion
2019-01-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994640 on ClinicalTrials.gov